Drugmaker Johnson & Johnson said Wednesday it had found a quality problem at a Baltimore plant helping manufacture its single-dose coronavirus vaccine under contract.
Drugmaker Johnson & Johnson said Wednesday it had found a quality problem at a Baltimore plant helping manufacture its single-dose coronavirus vaccine under contract.
Drugmaker Johnson & Johnson said Wednesday it had found a quality problem at a Baltimore plant helping manufacture its single-dose coronavirus vaccine under contract.
Maryland [US], April 1 (ANI): US pharmaceutical giant Johnson & Johnson has found a quality issue at a plant in Baltimore, Maryland helping manufacture its single-dose COVID-19 vaccine. The mix-up has said to have ruined as many as 15 million potential doses of vaccine.
Quality issue at vaccine plant delays some of Johnson & Johnson s vaccine kitv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kitv.com Daily Mail and Mail on Sunday newspapers.